Seeking Alpha

Johnson & Johnson's (JNJ) Pharmaceuticals Business Review is just getting underway (webcast)...

Johnson & Johnson's (JNJ) Pharmaceuticals Business Review is just getting underway (webcast) (agenda) (presentation). The company anticipates more than 10 new product filings and 25 significant brand extensions by 2017. Shares -1.2% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)